Non-small Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for the folate-tubulin conjugate EC-1456 in patients with advanced solid tumors, including non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients [Phase 2]
Phase 2 trial update evaluating afatinib for non-small-cell lung cancer, reporting efficacy and safety in completed study.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. [Phase 2]
Phase 2 trial of metformin combined with paclitaxel/carboplatin/bevacizumab in non-small cell lung cancer (lung adenocarcinoma) was terminat…
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) [Phase 3]
Phase 3 trial update for avelumab in non-small cell lung cancer (JAVELIN Lung 200) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Study of Tarceva and Targretin in Stage I-II Lung Cancer [NA]
A completed clinical trial evaluating Tarceva and Targretin for stage I-II non-small cell lung cancer with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer [Phase 2]
Phase 2 trial update of Tarceva and Targretin oral capsules in advanced non-small-cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC [Phase 3]
Phase 3 trial comparing S-1 to pemetrexed as maintenance therapy in advanced non-small cell lung cancer is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for a study in non-small cell lung cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-02-08Clinical Trial Update: Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of Erlotinib (Tarceva) in patients with advanced non-small cell lung cancer who failed prior chemotherapy has complet…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) [Phase 4]
Phase 4 trial update for afatinib in EGFR-positive non-small cell lung cancer patients with poor performance status has been terminated; res…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial assessing feasibility of cetuximab with concomitant radiotherapy and chemotherapy in locally advanced non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2017-09-13Clinical Trial Update: Non-small Cell Lung Cancer Study US75 (Z-PACT) [Phase 3]
Phase 3 clinical trial update for a non-small cell lung cancer study (US75/Z-PACT) completed.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) [Phase 3]
Phase 3 trial comparing pembrolizumab to platinum-based chemotherapy in metastatic non-small cell lung cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC [Phase 2]
Phase 2 clinical trial update for SNS-595 as second-line therapy in advanced non-small cell lung cancer (NSCLC) has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Phase I, Study in Chinese NSCLC Patients [Phase 1]
Phase I trial in Chinese patients with EGFR-mutated non-small cell lung carcinoma completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating vorinostat and bortezomib as third-line therapy in advanced non-small cell lung cancer has completed with results p…
-
EMA withdrawal · 2016-06-22EMA Application withdrawn: Xegafri — Clovis Oncology UK Ltd
The EMA withdrew the Xegafri application from Clovis Oncology UK Ltd for non-small cell lung carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation [Phase 2]
Phase 2 trial of dasatinib in advanced cancers with DDR2 or B-RAF mutations was terminated; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of OSI-774 in African American patients with advanced and previously treated non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2007-04-11Clinical Trial Update: Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
A clinical trial update examining whether hypercoagulable parameters can predict thrombotic events and prognosis in patients with advanced n…